Ocular Oncology

Top Story

Ophthalmic diffuse large B-cell lymphoma survival affected by different factors

September 18, 2017

Several factors, including increased age and location, can influence overall survival rates in patients with ophthalmic diffuse large B-cell lymphoma, according to a study.

Researchers evaluated the November 2016 submission of the National Cancer Institute’s Surveillance, Epidemiology, and End Results database for patients diagnosed with diffuse large B-cell lymphoma (DLBCL) from Jan. 1, 1973, to Dec. 31, 2014. The retrospective analysis included 396 patients and evaluated disease location, patient demographic characteristics and treatment modalities, and how these factors affected overall patient survival.

In the Journals

Protein immunoreactivity associated with uveal melanoma metastasis

August 30, 2017
BAP1 immunohistochemical staining of primary uveal melanoma showed high capability to evaluate metastatic risk in a study. BRCA1-associated protein 1 (BAP1) is one of…
Meeting News

Older patients at higher risk for class 2 uveal melanoma tumors

August 16, 2017
BOSTON — Class 2 uveal melanoma tumors are associated with older age, tumor size, ciliary body involvement and exudative retinal detachment, according to a poster…
Meeting News

Molecular genomics guides targeted uveal melanoma therapy

August 15, 2017
BOSTON — Uveal melanoma management is undergoing significant changes that enable improved survival for patients, improved globe retention and excellent visual…
More Headlines »
Original Article

Regular Versus Releasable Sutures in Surgery for Primary Congenital Glaucoma

Journal of Pediatric Ophthalmology and Strabismus, September/October 2017, Volume 54 Issue 5
To compare releasable and regular sutures in combined angle and filtering surgery for primary congenital glaucoma. A…
More »
CME CE

EDUCATION FOR THE REFERRING EYE CARE SPECIALIST

Diagnosis and Treatment of Myopic Choroidal Neovascularization: Earlier is Better

This activity is supported by an educational grant from Genentech, Inc.

This activity for comprehensive ophthalmologists and optometrists reviews the pathology and symptoms of mCNV; makes…
More »
Resource Centers
American Society of Retina Specialists Meeting

American Society of Retina Specialists Meeting

Video
Meeting News

VIDEO: Effective therapies needed for uveal melanoma

March 30, 2017
More »
Advertisement
Advertisement